Culbertson A N & Co’s Pfizer PFE Stock Holding History

Culbertson A N & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,582	Closed	-$213K	–	141
2026 Q1	$213K	Sell	7,582 -3,575	-32%	-$95.2K	0.03%	129
2025 Q4	$278K	Sell	11,157 -2,720	-20%	-$68.6K	0.04%	122
2025 Q3	$354K	Sell	13,877 -2,300	-14%	-$56.8K	0.05%	118
2025 Q2	$392K	Sell	16,177 -4,865	-23%	-$113K	0.06%	113
2025 Q1	$533K	Sell	21,042 -1,443	-6%	-$37.8K	0.09%	109
2024 Q4	$597K	Buy	22,485 +700	+3%	+$19K	0.09%	105
2024 Q3	$630K	Sell	21,785 -410	-2%	-$12K	0.1%	103
2024 Q2	$621K	Buy	22,195 +360	+2%	+$9.91K	0.11%	99
2024 Q1	$606K	Buy	21,835 +4,275	+24%	+$119K	0.1%	102
2023 Q4	$506K	Buy	17,560 +5,705	+48%	+$172K	0.09%	103
2023 Q3	$393K	Buy	11,855 +1,135	+11%	+$40.1K	0.08%	106
2023 Q2	$393K	Buy	10,720 +1,600	+18%	+$62.3K	0.08%	104
2023 Q1	$372K	Buy	9,120 +1,200	+15%	+$51.8K	0.08%	105
2022 Q4	$406K	Hold	7,920	–	–	0.09%	102
2022 Q3	$346K	Buy	7,920 +650	+9%	+$31.6K	0.08%	104
2022 Q2	$381K	Hold	7,270	–	–	0.08%	104
2022 Q1	$376K	Hold	7,270	–	–	0.07%	105
2021 Q4	$429K	Hold	7,270	–	–	0.08%	104
2021 Q3	$312K	Buy	+7,270	New	+$322K	0.06%	104

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Culbertson A N & Co's PFE Position: Q2 2026 in Review

Culbertson A N & Co sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,582 shares — an estimated $213K sold.

Culbertson A N & Co first reported a position in PFE in Q3 2021 and held it in 19 quarters. The position peaked at $630K in Q3 2024. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Culbertson A N & Co reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Culbertson A N & Co sold 7,582 Pfizer shares in Q2 2026, an estimated $213K.
Culbertson A N & Co first reported a position in Pfizer in Q3 2021 and held it in 19 quarters.
Culbertson A N & Co's Pfizer position peaked at $630K in Q3 2024.
2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Culbertson A N & Co's 13F filing for Q2 2026, filed 29 Jul 2026.